ESIF.DE vs. BTEK.L
ESIF.DE (iShares MSCI Europe Financials Sector UCITS ETF EUR (Acc)) and BTEK.L (iShares Nasdaq US Biotechnology UCITS ETF) are both exchange-traded funds - ESIF.DE is a Financials Equities fund tracking the MSCI World/Financials NR USD, while BTEK.L is a Health & Biotech Equities fund tracking the NASDAQ Biotechnology TR USD. Both are passively managed. Over the past 5 years, ESIF.DE returned 19.48%/yr vs 5.71%/yr for BTEK.L. At a 0.25 correlation, their price movements are largely independent. ESIF.DE charges 0.18%/yr vs 0.35%/yr for BTEK.L.
Performance
ESIF.DE vs. BTEK.L - Performance Comparison
Loading charts...
Different Trading Currencies
ESIF.DE is traded in EUR, while BTEK.L is traded in GBP. To make them comparable, the BTEK.L values have been converted to EUR using the latest available exchange rates.
Returns By Period
In the year-to-date period, ESIF.DE achieves a 3.87% return, which is significantly lower than BTEK.L's 5.80% return.
ESIF.DE
- 1D
- 0.61%
- 1M
- 3.50%
- YTD
- 3.87%
- 6M
- 10.14%
- 1Y
- 22.51%
- 3Y*
- 28.94%
- 5Y*
- 19.48%
- 10Y*
- —
BTEK.L
- 1D
- 3.47%
- 1M
- 2.06%
- YTD
- 5.80%
- 6M
- 3.73%
- 1Y
- 39.41%
- 3Y*
- 10.02%
- 5Y*
- 5.71%
- 10Y*
- —
ESIF.DE vs. BTEK.L - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
ESIF.DE iShares MSCI Europe Financials Sector UCITS ETF EUR (Acc) | 3.87% | 47.69% | 25.31% | 21.61% | -2.88% | 29.09% | 3.24% |
BTEK.L iShares Nasdaq US Biotechnology UCITS ETF | 5.80% | 17.35% | 4.49% | 2.46% | -6.63% | 7.46% | 6.58% |
Correlation
The correlation between ESIF.DE and BTEK.L is 0.29, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.29 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.29 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.27 |
Correlation (All Time) Calculated using the full available price history since Nov 23, 2020 | 0.25 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ESIF.DE vs. BTEK.L — Risk / Return Rank
ESIF.DE
BTEK.L
ESIF.DE vs. BTEK.L - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for iShares MSCI Europe Financials Sector UCITS ETF EUR (Acc) (ESIF.DE) and iShares Nasdaq US Biotechnology UCITS ETF (BTEK.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| ESIF.DE | BTEK.L | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.80 | ||
| Sortino ratioReturn per unit of downside risk | -1.10 | ||
| Omega ratioGain probability vs. loss probability | 1.22 | 1.34 | -0.12 |
| Calmar ratioReturn relative to maximum drawdown | 1.81 | 6.26 | -4.45 |
| Martin ratioReturn relative to average drawdown | 6.04 | 16.76 | -10.72 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| ESIF.DE | BTEK.L | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.25 | 2.05 | -0.80 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 1.02 | 0.28 | +0.74 |
Sharpe Ratio (All Time)Calculated using the full available price history | 1.16 | 0.33 | +0.84 |
Drawdowns
ESIF.DE vs. BTEK.L - Drawdown Comparison
The maximum ESIF.DE drawdown since its inception was -22.93%, smaller than the maximum BTEK.L drawdown of -31.09%. Use the drawdown chart below to compare losses from any high point for ESIF.DE and BTEK.L.
Loading charts...
Drawdown Indicators
| ESIF.DE | BTEK.L | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -22.93% | -31.09% | +8.16% |
Max Drawdown (1Y)Largest decline over 1 year | -12.38% | -6.26% | -6.12% |
Max Drawdown (3Y)Largest decline over 3 years | -17.10% | -28.63% | +11.53% |
Max Drawdown (5Y)Largest decline over 5 years | -22.93% | -31.09% | +8.16% |
Current DrawdownCurrent decline from peak | -2.65% | -1.23% | -1.42% |
Average DrawdownAverage peak-to-trough decline | -4.14% | -10.02% | +5.88% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.72% | 2.34% | +1.38% |
Volatility
ESIF.DE vs. BTEK.L - Volatility Comparison
The current volatility for iShares MSCI Europe Financials Sector UCITS ETF EUR (Acc) (ESIF.DE) is 5.37%, while iShares Nasdaq US Biotechnology UCITS ETF (BTEK.L) has a volatility of 6.60%. This indicates that ESIF.DE experiences smaller price fluctuations and is considered to be less risky than BTEK.L based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ESIF.DE | BTEK.L | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.37% | 6.60% | -1.23% |
Volatility (6M)Calculated over the trailing 6-month period | 14.59% | 14.39% | +0.20% |
Volatility (1Y)Calculated over the trailing 1-year period | 17.99% | 19.14% | -1.15% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 18.96% | 20.39% | -1.43% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 18.84% | 21.96% | -3.12% |
ESIF.DE vs. BTEK.L - Expense Ratio Comparison
ESIF.DE has a 0.18% expense ratio, which is lower than BTEK.L's 0.35% expense ratio.
Dividends
ESIF.DE vs. BTEK.L - Dividend Comparison
Neither ESIF.DE nor BTEK.L has paid dividends to shareholders.
Frequently Asked Questions
ESIF.DE and BTEK.L have a correlation of 0.29, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, ESIF.DE is cheaper at 0.18% per year. The better choice depends on whether you care most about return, fees, risk, or income.
ESIF.DE is cheaper with a 0.18% expense ratio, compared with 0.35% for BTEK.L.
ESIF.DE is categorized as Financials Equities, while BTEK.L is Health & Biotech Equities. ESIF.DE tracks MSCI World/Financials NR USD, while BTEK.L tracks NASDAQ Biotechnology TR USD. Their fees differ too: 0.18% for ESIF.DE and 0.35% for BTEK.L.
Find the right allocation for ESIF.DE and BTEK.L
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer